Alzinova - higher risk, higher rewardAlzinova is an early stage pharma company developing a vaccine for Alzheimers through very specific targeting with their candidate ALZ-101.
This is an interesting chart I think, as we can see the stock has fallen to it's lowest level for a long time. Company is currently issuing 50m SEK of shares with guaranteed commitments of 46.7m SEK from investors.
Couple of reasons I find this an interesting potential investment,
- finding a vaccine for Alzheimers would be massive
- early stage (phase 1) and price reflects the risk in this
- approx 1.5m shares bought on 15th at a higher price than it is now indicating to me that there is a lot of upside and little appetite for short interest.
As always with a early stage drug you have to have confidence that there will be good news from clinical trials (nothing new on this til Q1 2021) and you may not see a return on your investment till 2022. This one is for the longs more than likely.
I am not currently invested in this stock but have it on my watchlist to see if there will be a further dip for better entry position.
As always this is just an idea and it is higher risk than I would normally talk about, upside however is prob 100% in one year if there is positive news in Q1 2021...
stay safe
